Think Research, Part of Orion Health’s Better Access Alliance, Awarded Five-Year $5.2M Ontario-Wide Contract to Help Patients Access Health Care Information and Services

November 15, 2021

Think Research Acquires the Assets of Competitor Pharmapod Limited, including its International Medication Error Reporting Software

November 5, 2021
Think Research Corporation is pleased to announce today it has acquired the assets of Pharmapod Limited through a receivership process in Ireland.

Think Research Appoints Former Ontario Health Minister Dr. Eric Hoskins as Chair of its Board of Directors

October 28, 2021

Dr. Hoskins brings more than 30 years of experience in healthcare and public policy to his role

TORONTO, ON, October 28, 2021 – Think Research Corporation (TSXV: THNK) (“Think” or the “Company“), a company focused on transforming healthcare through digital health software solutions, is pleased to announce today it has appointed former Ontario Health Minister Dr. Eric Hoskins as the Chair of the Company’s Board of Directors.

Think Research Corporation Closes Acquisition of Bio Pharma Services Inc.

September 13, 2021
Toronto, ON, September 13, 2021 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has closed its previously announced acquisition of all of the issued and outstanding shares of BioPharma, a leading contract research organization to pharmaceutical companies globally, from its securityholders (the “BioPharma Securityholders”).  Think CEO Sachin Aggarwal said, “We extend a warm welcome from the Think family to the talented BioPharma team. The closing of this acquisition offers not just immediate financial value to our shareholders, but it also represents a key pillar in our knowledge lifecycle, allowing us to utilize systems and solutions that support the clinical decision-making process, standardize care, and, ultimately, improve patient outcomes. We look forward to supporting BioPharma in its digital transformation to create synergies in the near term.” Visit the Think Research website to view the full release.

Think Research Finds Mental Health Is the Top Issue Healthcare Providers Want to Educate Themselves On

September 9, 2021
TORONTO, ON, September 9, 2021  – Think Research Corporation, a company focused on transforming healthcare through digital health software solutions, today announced survey results showing six in 10 Canadian clinicians say mental health is the top healthcare issue they want to further educate themselves on. The survey, led by MDBriefCase, the leading provider of continuing medical education and a member of the Think family of companies, found that nearly 62 per cent of healthcare providers ranked mental health is the most valuable therapeutic area of continuing education for them, signalling the importance of supporting patients’ ongoing well-being coming out of the COVID-19 crisis. Research shows that mental health has declined across age groups during the pandemic, including children and adolescents, adults, frontline workers and seniors. Early mental health intervention and treatment is shown to improve outcomes and reduce healthcare spending. Think’s Senior Medical Advisor Dr. Naila Kassam said “Almost half of all Canadians say their mental health has worsened since the start of the pandemic. The fact that clinicians report a strong desire to learn more about mental health and continue their education shows how seriously they are taking it as a core part of someone’s overall well-being. “As best […]

Think Research Completes Acquisition of MDBriefCase, an International Provider of Accredited Digital Education to Clinicians

January 29, 2021
Original press release posted on CNW.Jan 29, 2021, 13:00 ET Strategic acquisition positions Think Research to educate clinicians internationally on the latest evidence and protocols and also to provide them with the digital tools required to immediately deploy that knowledge into their practice, thereby improving patient care, safety and outcomes Combined, Think Research and MDBriefCase reach a network of nearly 300,000 global healthcare professionals in Canada, Europe, Australia, Africa and the Middle East With the acquisition of MDBriefCase, trailing pro forma revenue grows to more than $36M TORONTO, Jan. 29, 2021 /CNW/ – Think Research Corporation (TSXV: THNK) or (the “Company” or “Think Research“), a company focused on transforming healthcare through integrated digital health solutions, today announced that it has completed the previously announced definitive agreement to acquire all of the issued and outstanding shares of MDBriefCase Group Inc. (“MDBriefCase“), a leading provider of online continuing medical education (“CME“) and professional development solutions for clinicians and a portfolio company of Persistence Capital Partners. The acquisition was made for an aggregate purchase price of $25.3M in Think Research shares and cash, and a total enterprise value of $28.5M. Sachin Aggarwal, CEO of Think Research, said, “This is a highly strategic acquisition for Think Research and we are eager to get going on integrating MDBriefCase […]

Think Research Corp. acquires MDBriefCase Group Inc.

January 19, 2021
TORONTO, Jan. 18, 2021 – Think Research Corporation, a company focused on transforming healthcare through integrated digital health solutions, today announced that it has entered into a share purchase agreement to acquire all of the issued and outstanding shares of MDBriefCase Group Inc. (“MDBriefCase”), a leading provider of online continuing medical education (CME) and professional development solutions for clinicians and a portfolio company of Persistence Capital Partners. Through this transaction (the “Transaction”), Think Research will be uniquely positioned to educate clinicians internationally on the latest evidence and protocols and also to provide them with the digital tools required to immediately deploy that knowledge into their practice, thereby improving patient care, safety and outcomes. The combination of Think Research and MDBriefCase is expected to create a valuable data feedback loop where data collected through frontline clinical tools can monitor how a clinician’s practice has changed as a result of CME and other programs, and whether adjustments need to be made to further improve CME courses or clinical decision support tools. The Transaction builds on the Company’s momentum and scale following the commencement of its listing on the TSX Venture Exchange (the “TSXV”) on December 30, 2020 and the announcement on January […]

MDBriefCase and IQVIA collaborate to provide access to specialized e-learning and engagement for HCPs in the Middle East, Africa and South Asia

January 4, 2021
4th January 2021: MDBriefcase Group Inc. (MDBC), Canada’s leading provider of online continuing medical education and professional development for healthcare providers, is excited to announce a strategic alliance with IQVIA in the Middle East, Africa and South Asia. IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Through this alliance, HCPs can access on-demand medical e-learning solutions and engagement services by MDBC on IQVIAs HCP Space™, a holistic networking and learning platform for healthcare professionals. With over 54,000 registered users it is one of the fastest growing platforms in the region. Professionals on HCP Space will gain access to MDBCs latest content, digital networks, and learning resources available. “We are thrilled to have the opportunity to partner with IQVIA to build upon a collective vision we share to connect and support the healthcare community. We now offer a wider and more impactful range of education and communication initiatives,” said Janet Kimura, SVP of MDBC. “This collaboration reflects our ongoing commitment to growth and enabling the healthcare community to quickly and practically integrate evidence, medical insights and knowledge from a preeminent platform that will improve the lives of the patients.” […]